Enovis (ENOV) Capital Expenditures Growth (3y) (2013 - 2026)
Enovis (ENOV) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.52% |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | 6.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 6.05% |
| Apr 3, 2026 | 20.15% |
| Dec 31, 2025 | 15.21% |
| Oct 3, 2025 | 36.85% |
| Jul 4, 2025 | 23.24% |
| Apr 4, 2025 | 21.55% |
| Dec 31, 2024 | 20.18% |
| Sep 27, 2024 | 20.92% |
| Jun 28, 2024 | 25.15% |
| Mar 29, 2024 | 14.60% |
| Dec 31, 2023 | -5.58% |
| Sep 29, 2023 | -4.62% |
| Jun 30, 2023 | 23.98% |
| Mar 31, 2023 | -0.72% |
| Dec 31, 2022 | 13.71% |
| Sep 30, 2022 | -16.94% |
| Jul 1, 2022 | -15.72% |
| Apr 1, 2022 | -0.37% |
| Dec 31, 2021 | 1.39% |
| Oct 1, 2021 | 23.32% |